In order to understand the potential of anti‐macrophage therapy concerning blood vessel function and glioma progression, we inhibited macrophage recruitment in the tumor microenvironment using anti‐CSF1 monoclonal antibody treatment. The gene discussed is CSF1; the disease is central nervous system cancer.